Genetic Determinants Influencing Human Serum Metabolome among African Americans

PLoS Genetics

Volumn 10, Issue 3, 2014, Pages

  Yu, Bing ^a   Zheng, Yan ^a   Alexander, Danny ^b   Morrison, Alanna C ^a   Coresh, Josef ^c   Boerwinkle, Eric ^a,d  

^a UNIVERSITY OF TEXAS   (United States)

^b METABOLON INC   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; TREHALOSE; ACYLTRANSFERASE; NAT8 PROTEIN, HUMAN;

ACE GENE; ACETYLATION; ACSM2B GENE; ACY3 GENE; ADH4 GENE; AFRICAN AMERICAN; ARTICLE; CARDIOVASCULAR DISEASE; CAUCASIAN; CHRONIC KIDNEY DISEASE; CPS1 GENE; DIABETES MELLITUS; ENDOPHENOTYPE; ETHNIC DIFFERENCE; GATM GENE; GENE; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; KLKB1 GENE; MAJOR CLINICAL STUDY; METABOLOME; MISSENSE MUTATION; NAT8 GENE; RISK FACTOR; SIAE GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SLC6A13 GENE; TREH GENE; UGT1A GENE; ALLELE; ATHEROSCLEROSIS; BLOOD; GENETICS; METABOLISM; PATHOLOGY; PHENOTYPE;

ACETYLTRANSFERASES; AFRICAN AMERICANS; ALLELES; ATHEROSCLEROSIS; DIABETES MELLITUS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; METABOLOME; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; TREHALOSE;

EID: 84897399605     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1004212     Document Type: Article

References (43)

1. Psaty BM, O'Donnell CJ, Gudnason V, Lunetta KL, Folsom AR, et al. (2009) Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: Design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ Cardiovasc Genet 2: 73-80.
2. German JB, Hammock BD, Watkins SM, (2005) Metabolomics: building on a century of biochemistry to guide human health. Metabolomics 1: 3-9.
3. Suhre K, Gieger C, (2012) Genetic variation in metabolic phenotypes: study designs and applications. Nat Rev Genet 13: 759-769.
4. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, et al. (2010) Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466: 707-713.
5. Surakka I, Whitfield JB, Perola M, Visscher PM, Montgomery GW, et al. (2012) A genome-wide association study of monozygotic twin-pairs suggests a locus related to variability of serum high-density lipoprotein cholesterol. Twin Res Hum Genet 15: 691-699.
6. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, et al. (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42: 105-116.
7. Kottgen A, Albrecht E, Teumer A, Vitart V, Krumsiek J, et al. (2013) Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet 45: 145-154.
8. Gieger C, Geistlinger L, Altmaier E, Hrabe de Angelis M, Kronenberg F, et al. (2008) Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. PLoS Genet 4: e1000282.
9. Suhre K, Wallaschofski H, Raffler J, Friedrich N, Haring R, et al. (2011) A genome-wide association study of metabolic traits in human urine. Nat Genet 43: 565-569.
10. Suhre K, Shin SY, Petersen AK, Mohney RP, Meredith D, et al. (2011) Human metabolic individuality in biomedical and pharmaceutical research. Nature 477: 54-60.
11. Kettunen J, Tukiainen T, Sarin AP, Ortega-Alonso A, Tikkanen E, et al. (2012) Genome-wide association study identifies multiple loci influencing human serum metabolite levels. Nat Genet 44: 269-276.
12. Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, et al. (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature 449: 851-861.
13. Campbell MC, Tishkoff SA, (2008) African genetic diversity: implications for human demographic history, modern human origins, and complex disease mapping. Annu Rev Genomics Hum Genet 9: 403-433.
14. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, et al. (2009) Finding the missing heritability of complex diseases. Nature 461: 747-753.
15. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, et al. (2013) Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 127: e6-e245.
16. Tarver-Carr ME, Powe NR, Eberhardt MS, LaVeist TA, Kington RS, et al. (2002) Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors. J Am Soc Nephrol 13: 2363-2370.
17. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.
18. Xie W, Wood AR, Lyssenko V, Weedon MN, Knowles JW, et al. (2013) Genetic variants associated with glycine metabolism and their role in insulin sensitivity and type 2 diabetes. Diabetes 62: 2141-2150.
19. Veiga-da-Cunha M, Tyteca D, Stroobant V, Courtoy PJ, Opperdoes FR, et al. (2010) Molecular identification of NAT8 as the enzyme that acetylates cysteine S-conjugates to mercapturic acids. J Biol Chem 285: 18888-18898.
20. Zheng Y, Yu B, Alexander D, Manolio TA, Aguilar D, et al. (2013) Associations between metabolomic compounds and incident heart failure among African Americans: the ARIC Study. Am J Epidemiol 178: 534-542.
21. Kottgen A, Pattaro C, Boger CA, Fuchsberger C, Olden M, et al. (2010) New loci associated with kidney function and chronic kidney disease. Nat Genet 42: 376-384.
22. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, et al. (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 106: 9362-9367.
23. Park JH, Gail MH, Weinberg CR, Carroll RJ, Chung CC, et al. (2011) Distribution of allele frequencies and effect sizes and their interrelationships for common genetic susceptibility variants. Proc Natl Acad Sci U S A 108: 18026-18031.
24. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447: 661-678.
25. Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, et al. (2007) Genomewide association analysis of coronary artery disease. N Engl J Med 357: 443-453.
26. Erdmann J, Grosshennig A, Braund PS, Konig IR, Hengstenberg C, et al. (2009) New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat Genet 41: 280-282.
27. Illig T, Gieger C, Zhai G, Romisch-Margl W, Wang-Sattler R, et al. (2010) A genome-wide perspective of genetic variation in human metabolism. Nat Genet 42: 137-141.
28. Ozaki K, Fujiwara T, Nakamura Y, Takahashi E, (1998) Isolation and mapping of a novel human kidney- and liver-specific gene homologous to the bacterial acetyltransferases. J Hum Genet 43: 255-258.
29. Chambers JC, Zhang W, Lord GM, van der Harst P, Lawlor DA, et al. (2010) Genetic loci influencing kidney function and chronic kidney disease. Nat Genet 42: 373-375.
30. Tin A, Colantuoni E, Boerwinkle E, Kottgen A, Franceschini N, et al. (2013) Using multiple measures for quantitative trait association analyses: application to estimated glomerular filtration rate. J Hum Genet 58: 461-6.
31. Jain NK, Roy I, (2009) Effect of trehalose on protein structure. Protein Sci 18: 24-36.
32. Tanaka M, Machida Y, Niu S, Ikeda T, Jana NR, et al. (2004) Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease. Nat Med 10: 148-154.
33. Davies JE, Sarkar S, Rubinsztein DC, (2006) Trehalose reduces aggregate formation and delays pathology in a transgenic mouse model of oculopharyngeal muscular dystrophy. Hum Mol Genet 15: 23-31.
34. Richards AB, Krakowka S, Dexter LB, Schmid H, Wolterbeek AP, et al. (2002) Trehalose: a review of properties, history of use and human tolerance, and results of multiple safety studies. Food Chem Toxicol 40: 871-898.
35. Wu C, Kraft P, Zhai K, Chang J, Wang Z, et al. (2012) Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions. Nat Genet 44: 1090-1097.
36. You YJ, Kim Y, Nam NH, Bang SC, Ahn BZ, (2004) Alkyl and carboxylalkyl esters of 4′-demethyl-4-deoxypodophyllotoxin: synthesis, cytotoxic, and antitumor activity. Eur J Med Chem 39: 189-193.
37. Casiglia E, Spolaore P, Ginocchio G, Ambrosio GB, (1993) Unexpected effects of coffee consumption on liver enzymes. Eur J Epidemiol 9: 293-297.
38. Krumsiek J, Suhre K, Evans AM, Mitchell MW, Mohney RP, et al. (2012) Mining the unknown: a systems approach to metabolite identification combining genetic and metabolic information. PLoS Genet 8: e1003005.
39. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol 129: 687-702.
40. Ohta T, Masutomi N, Tsutsui N, Sakairi T, Mitchell M, et al. (2009) Untargeted metabolomic profiling as an evaluative tool of fenofibrate-induced toxicology in Fischer 344 male rats. Toxicol Pathol 37: 521-535.
41. Evans AM, DeHaven CD, Barrett T, Mitchell M, Milgram E, (2009) Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal Chem 81: 6656-6667.
42. Grambsch PM, Therneau TM, (1994) Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81: 515-526.
43. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, et al. (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612.